Faculty Collaboration Database

Policy statement--recommendations for prevention and control of influenza in children, 2010-2011. Pediatrics 2010 Oct;126(4):816-26

Date

09/02/2010

Pubmed ID

20805143

DOI

10.1542/peds.2010-2216

Scopus ID

2-s2.0-77957708165 (requires institutional sign-in at Scopus site)   32 Citations

Abstract

The purpose of this statement is to update current recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The 2009 influenza A (H1N1) pandemic virus is expected to circulate, with infants and children at increased risk of severe illness and death. This year's trivalent seasonal influenza vaccine contains A/California/7/2009 (H1N1)-like antigen (derived from the 2009 pandemic influenza A [H1N1] virus); A/Perth/16/2009 (H3N2)-like antigen; and B/Brisbane/60/2008-like antigen. Pediatricians continue to have a leadership role in the prevention of influenza through vaccine use and public education. In addition, pediatricians should promptly identify influenza infections to enable rapid treatment of influenza, when indicated, to reduce childhood morbidity and mortality.

Author List

American Academy of Pediatrics. Committee on Infectious Diseases

Author

Rodney E. Willoughby MD Professor in the Pediatrics department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Child
Child, Preschool
Humans
Immunization
Infant
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H3N2 Subtype
Influenza Vaccines
Influenza, Human